$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
Can the broad-spectrum anticancer drug larotrectinib be reimbursed by medical insurance?
2025-10-19 11:44:20
Check Details
Can cabozantinib (XL184) improve quality of life in metastatic RCC?
2025-10-19 11:44:20
Check Details
Data on the efficacy of larotrectinib in the treatment of NTRK-positive lung cancer
2025-10-19 11:44:20
Check Details
Precautions for using larotinib in patients with lung cancer
2025-10-19 11:44:20
Check Details
The cost of larotrectinib treatment for lung cancer _ Kanghule
2025-10-19 11:44:20
Check Details
Is the NTRK inhibitor larotrectinib covered by medical insurance?
2025-10-19 11:44:20
Check Details
Larotrectinib brings new options to patients with NRTK-positive lung cancer
2025-10-19 11:44:20
Check Details
How long can patients with liver cancer live after regorafenib treatment?
2025-10-19 11:44:20
Check Details
Larotinib is a broad-spectrum anti-tumor drug applied to the NTRK target_ Kanghule
2025-10-19 11:44:20
Check Details
How much does a box of NTRK gene fusion targeting drug larotrectinib cost? Where can I buy it?
2025-10-19 11:44:20
Check Details
How should larotrectinib, which is different from traditional targeted drugs targeting the primary site, be taken?
2025-10-19 11:44:20
Check Details
Larotrectinib can be used to treat patients with NTRK gene fusions_Canghule
2025-10-19 11:44:20
Check Details
1
2
...
9961
9962
9963
9964
9965
9966
9967
...
10204
10205
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
What diseases can Upatinib be used for? Which patients are suitable for use?
2
The efficacy of Eltrombopag
3
User Agreement
4
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
5
What is the most important information I should know about WELIREG?
6
How to take and store WELIREG
7
How to take TRUSELTIQ correctly
8
How to deal with LONSURF side effects (1)
9
How to deal with LONSURF side effects (2)
10
Cabozantinib (Cabometyx)-new indication approved
11
What should I pay attention to when using atezolizumab/Tecentriq?
12
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma